174 related articles for article (PubMed ID: 32368615)
21. Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-κB signaling.
Qiang J; Lv T; Wu Z; Yang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239367
[TBL] [Abstract][Full Text] [Related]
22. Targeted p21 activation by a new double stranded RNA suppresses human prostate cancer cells growth and metastasis.
Zhang Q; Yang X; Luo L; Ma X; Jiao W; Li B; Zhang M; Zhao K; Niu H
Am J Transl Res; 2020; 12(8):4175-4188. PubMed ID: 32913496
[TBL] [Abstract][Full Text] [Related]
23. NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN.
Akgun S; Kucuksayan H; Ozes ON; Can O; Alikanoglu AS; Yildiz M; Akca H
Anticancer Agents Med Chem; 2019; 19(8):1058-1068. PubMed ID: 30727918
[TBL] [Abstract][Full Text] [Related]
24. MiR-142-3p functions as an oncogene in prostate cancer by targeting FOXO1.
Tan YF; Chen ZY; Wang L; Wang M; Liu XH
J Cancer; 2020; 11(6):1614-1624. PubMed ID: 32047567
[TBL] [Abstract][Full Text] [Related]
25. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer.
Li W; Li S; Yang J; Cui C; Yu M; Zhang Y
Onco Targets Ther; 2019; 12():3753-3763. PubMed ID: 31190876
[No Abstract] [Full Text] [Related]
26. MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.
Sui GQ; Fei D; Guo F; Zhen X; Luo Q; Yin S; Wang H
Am J Cancer Res; 2017; 7(5):1177-1187. PubMed ID: 28560065
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
28. MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.
Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
Am J Cancer Res; 2017; 7(8):1738-1753. PubMed ID: 28861329
[TBL] [Abstract][Full Text] [Related]
29. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
30. miR-410-3p Suppresses Cytokine Release from Fibroblast-Like Synoviocytes by Regulating NF-κB Signaling in Rheumatoid Arthritis.
Wang Y; Xu N; Zhao S; Jiao T; Fu W; Yang L; Zhang N
Inflammation; 2019 Feb; 42(1):331-341. PubMed ID: 30242542
[TBL] [Abstract][Full Text] [Related]
31. LINC00482 sponged miR-2467-3p to promote bone metastasis of prostate cancer through activating Wnt/β-catenin signaling pathway.
Liao S; Fang X; Zhou K; Zhao T; Ji L; Zhang W; Zhong X; Feng F; Lv J; Kang Y; Zhu D
J Bone Oncol; 2023 Aug; 41():100494. PubMed ID: 37575527
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
33. miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6.
Wang N; Tao L; Zhong H; Zhao S; Yu Y; Yu B; Chen X; Gao J; Wang R
Oncol Lett; 2016 Jan; 11(1):543-550. PubMed ID: 26870245
[TBL] [Abstract][Full Text] [Related]
34. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
35. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
36. miR-33b-3p Acts as a Tumor Suppressor by Targeting
Mei Y; Li K; Zhang Z; Li M; Yang H; Wang H; Huang X; Li X; Shi S; Yang H
Front Oncol; 2021; 11():740452. PubMed ID: 34804930
[TBL] [Abstract][Full Text] [Related]
37. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
38. A novel microRNA-1207-3p/FNDC1/FN1/AR regulatory pathway in prostate cancer.
Das DK; Ogunwobi OO
RNA Dis; 2017; 4(1):. PubMed ID: 28251177
[TBL] [Abstract][Full Text] [Related]
39. miR-370-3p as a Novel Biomarker Promotes Breast Cancer Progression by Targeting FBLN5.
Mao J; Wang L; Wu J; Wang Y; Wen H; Zhu X; Wang B; Yang H
Stem Cells Int; 2021; 2021():4649890. PubMed ID: 34475958
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
